
Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53
Keywords: Colorectal cancer; Ceramide; C6-ceramide; Tamoxifen; P-glycoprotein; p53CRC, colorectal cancer; P-gp, P-glycoprotein; GCS, glucosylceramide synthase; GC, glucosylceramide; PARP, poly ADP ribose polymerase; MMP, mitochondrial membrane permeabilization; FBS